Key Points
- Insider Jeff Barlow sold 8,000 Molina Healthcare shares for about $1.62 million at an average price of $203.07, reducing his stake by 11.88% to 59,313 shares.
- Molina reported quarterly EPS of $0.89, beating the $0.79 analyst consensus, and revenue of $11.08 billion versus estimates of $10.86 billion. Revenue declined 3.4% year over year, while EPS was down from $1.84 in the year-ago quarter.
- Analysts’ consensus rating was Hold, with an average price target of $213.88; three rated the stock Buy, 13 Hold, and two Sell.
Molina Healthcare, Inc (NYSE:MOH - Get Free Report) insider Jeff Barlow sold 8,000 shares of Molina Healthcare stock in a transaction that occurred on Tuesday, November 10th. The shares were sold at an average price of $203.07, for a total transaction of $1,624,560.00. Following the completion of the transaction, the insider owned 59,313 shares of the company's stock, valued at $12,044,690.91. This trade represents a 11.88% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link.
Molina Healthcare Stock Down 0.2%
MOH traded down $0.48 during trading hours on Friday, hitting $209.37. 362,848 shares of the company's stock were exchanged, compared to its average volume of 997,807. Molina Healthcare, Inc has a 12-month low of $121.06 and a 12-month high of $244.89. The firm has a 50 day moving average of $202.56 and a 200 day moving average of $185.69. The firm has a market cap of $10.93 billion, a P/E ratio of -218.09, a price-to-earnings-growth ratio of 12.38 and a beta of 0.75. The company has a current ratio of 1.69, a quick ratio of 1.69 and a debt-to-equity ratio of 0.95.
Molina Healthcare (NYSE:MOH - Get Free Report) last released its earnings results on Wednesday, October 21st. The company reported $0.89 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.79 by $0.10. Molina Healthcare had a negative net margin of 0.11% and a positive return on equity of 2.50%. The company had revenue of $11.08 billion for the quarter, compared to analyst estimates of $10.86 billion. During the same period in the prior year, the business earned $1.84 EPS. The firm's quarterly revenue was down 3.4% on a year-over-year basis. Analysts predict that Molina Healthcare, Inc will post 5.30 EPS for the current fiscal year.
Analyst Upgrades and Downgrades
MOH has been the topic of several analyst reports. Robert W. Baird set a $198.00 price objective on Molina Healthcare in a research note on Friday, October 23rd. JPMorgan Chase & Co. lifted their target price on Molina Healthcare from $220.00 to $225.00 and gave the company a "neutral" rating in a report on Tuesday, October 27th. Wells Fargo & Company lowered their target price on Molina Healthcare from $235.00 to $220.00 and set an "equal weight" rating for the company in a research note on Tuesday, July 28th. Wall Street Zen upgraded Molina Healthcare from a "sell" rating to a "hold" rating in a report on Saturday, October 24th. Finally, Barclays reduced their price target on Molina Healthcare from $180.00 to $178.00 and set an "underweight" rating on the stock in a research report on Friday, October 23rd. Three analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and two have given a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Hold" and an average price target of $213.88.
Get Our Latest Report on Molina Healthcare
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently added to or reduced their stakes in MOH. BlackRock Inc. purchased a new position in Molina Healthcare in the second quarter valued at $1,503,052,000. Manning & Napier Advisors LLC acquired a new stake in Molina Healthcare in the second quarter valued at $152,339,000. Maverick Capital Ltd. purchased a new stake in Molina Healthcare during the 1st quarter worth about $86,081,000. Bank of New York Mellon Corp purchased a new stake in Molina Healthcare during the 2nd quarter worth about $86,138,000. Finally, Bank of America Corp DE purchased a new stake in Molina Healthcare during the 2nd quarter worth about $71,480,000. Institutional investors and hedge funds own 98.50% of the company's stock.
Trending Headlines about Molina Healthcare
Investors following MOH have been watching these headlines:
- Negative Sentiment: Zacks Research lowered its EPS estimates for Q1 2027 to $2.48 from $2.53, Q3 2027 to $2.17 from $2.23, and Q3 2028 to $3.85 from $4.06. The analyst firm maintained a Hold rating; the downward revisions may weigh on sentiment about Molina’s earnings outlook.
- Negative Sentiment: Three insiders reported selling a combined 10,382 shares for about $2.11 million, reducing their individual holdings by roughly 6% to 12%. These sales may be viewed as a negative signal, though insider transactions alone do not establish a change in the company’s fundamentals. Jeff Barlow SEC filing Richard Schapiro SEC filing Dale Wolf SEC filing
Molina Healthcare Company Profile
(
Get Free Report)
Molina Healthcare, Inc. is a managed care company that provides health insurance plans primarily to people covered by government-sponsored programs. Its offerings include Medicaid plans, Medicare plans for eligible individuals and dual-eligible members, and health plans sold through government marketplaces under the Affordable Care Act. The company was founded in 1980 by physician C. David Molina in Long Beach, California, initially serving low-income families through community clinics. It later shifted its focus to providing managed health care, with Medicaid becoming a central part of its business.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
